Early data from a clinical study suggest that an off-label cancer drug provided clinical benefit to a small group of patients with severe COVID-19.
from FOX News https://ift.tt/2AQgarQ
v
Monday, 8 June 2020
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment